Experiences with cefazolin: a new cephalosporin antibiotic.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001393:Azoles / Q000008:administration & dosage / Q000627:therapeutic use; D001991:Bronchitis / Q000188:drug therapy; D002481:Cellulitis / Q000188:drug therapy; D002511:Cephalosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D055598:Chemical Phenomena; D002621:Chemistry; D004653:Empyema / Q000188:drug therapy; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000188:drug therapy*; D011704:Pyelonephritis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013290:Streptococcal Infections / Q000188:drug therapy*; D013440:Sulfides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013830:Thiadiazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D001393:Azoles; D002511:Cephalosporins; D013440:Sulfides; D013830:Thiadiazoles